Friday, June 12, 2026

Patent directory Β· USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code β€” or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 1145 of 1,261
  1. US 2004208826

    Ultrasound contrast agents and methods of making and using them

    BRACCO INT BV [NL] Β· Granted Oct 21, 2004 Β· Expires Oct 16, 2024

    expired
  2. US 6806354

    Methods and compositions for inducing autoimmunity in the treatment of cancers

    The Board of Regents of the University of Texas System Β· Granted Oct 19, 2004 Β· Expires Oct 14, 2024

    expired
  3. US 6806363

    Cobalamin conjugates useful as antitumor agents

    Minnesota, Regents of the University Β· Granted Oct 19, 2004 Β· Expires Oct 14, 2024

    expired
  4. US 6805858

    Methods for the administration of adenovirus p53

    The Board of Regents of the University of Texas System Β· Granted Oct 19, 2004 Β· Expires Oct 14, 2024

    expired
  5. US 6806084

    Methods for compositions for in vivo gene delivery

    The Regents of the University of California Β· Granted Oct 19, 2004 Β· Expires Oct 14, 2024

    expired
  6. US 6806373

    Process for preparing leflunomide form I

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. Β· Granted Oct 19, 2004 Β· Expires Oct 14, 2024

    expired
  7. US 6806073

    Human kinase proteins and polynucleotides encoding the same

    Lexicon Genetics, Inc. Β· Granted Oct 19, 2004 Β· Expires Oct 14, 2024

    expired
  8. US 6806065

    Rickettsia felis outer membrane protein

    The Board of Regents of the University of Texas System Β· Granted Oct 19, 2004 Β· Expires Oct 14, 2024

    expired
  9. US 6806080

    Hybrid vectors for gene therapy

    The Regents of the University of California Β· Granted Oct 19, 2004 Β· Expires Oct 14, 2024

    expired
  10. US 6803486

    Selective neuronal nitric oxide synthase inhibitors

    Northwestern University Β· Granted Oct 12, 2004 Β· Expires Oct 7, 2024

    expired
  11. US 6803386

    Prostacyclin derivative containing compositions and methods of using the same for the treatment of cancer

    United Therapeutics Corporation Β· Granted Oct 12, 2004 Β· Expires Oct 7, 2024

    expired
  12. US 6803371

    Purine inhibitors of protein kinases, G proteins and polymerases

    The Regents of the University of California Β· Granted Oct 12, 2004 Β· Expires Oct 7, 2024

    expired
  13. US 6803375

    Non-peptide inhibition of T-lymphocyte activation and therapies related thereto

    The Regents of the University of California Β· Granted Oct 12, 2004 Β· Expires Oct 7, 2024

    expired
  14. US 6803359

    Inhibition of abnormal cell growth with corticotropin-releasing hormone analogs

    The Regents of the University of California Β· Granted Oct 12, 2004 Β· Expires Oct 7, 2024

    expired
  15. US 6803453

    Antibodies associated with alterations in bone density

    Darwin Discovery Limited Β· Granted Oct 12, 2004 Β· Expires Oct 7, 2024

    expired
  16. US 6803053

    Lipidic microparticles linked to multiple proteins

    The Regents of the University of California Β· Granted Oct 12, 2004 Β· Expires Oct 7, 2024

    expired
  17. US 6800778

    Process for producing optically active naphthalene derivative and optical resolver therefor

    Takeda Chemical Industries Ltd. Β· Granted Oct 5, 2004 Β· Expires Sep 30, 2024

    expired
  18. US 6800619

    Caspase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated Β· Granted Oct 5, 2004 Β· Expires Sep 30, 2024

    expired
  19. US 6800611

    Metastin derivatives and their use

    Takeda Chemical Industries Ltd. Β· Granted Oct 5, 2004 Β· Expires Sep 30, 2024

    expired
  20. US 6800759

    Racemization and enantiomer separation of clopidogrel

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. Β· Granted Oct 5, 2004 Β· Expires Sep 30, 2024

    expired
  21. US 6800626

    Inhibitors of p38

    Vertex Pharmaceuticals Incorporated Β· Granted Oct 5, 2004 Β· Expires Sep 30, 2024

    expired
  22. US 6800615

    Antihelminthic anthraquinones and method of use thereof

    The Regents of the University of California Β· Granted Oct 5, 2004 Β· Expires Sep 30, 2024

    expired
  23. US 6800745

    Indolicidin analogs and methods of using same

    The Regents of the University of California Β· Granted Oct 5, 2004 Β· Expires Sep 30, 2024

    expired
  24. US 6800475

    Isolation of a human retrovirus

    The United States of America, as represented by the Department of Health and Human Services Β· Granted Oct 5, 2004 Β· Expires Sep 30, 2024

    expired

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search β€” best for looking up a specific filing or applicant portfolio slice.